Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€490.00
08.07.21
-
08.07.22
21.00%
08.07.22

Saftman 
08.07.21 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€490.00
08.07.21
-
08.07.22
21.00%
08.07.22

Saftman 
08.07.21 50%
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.54
08.07.21
-
08.07.22
-50.39%
08.07.22

Maxi_Scalibusa 
08.07.21 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€22.94
08.07.21
-
08.07.22
-85.09%
08.07.22

Saftman 
08.07.21 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€142.86
08.07.21
-
08.07.22
22.71%
08.07.22

Saftman 
08.07.21 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€142.86
08.07.21
-
08.07.22
22.71%
08.07.22

Saftman 
08.07.21 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€38.17
08.07.21
-
08.07.22
30.25%
08.07.22

Saftman 
08.07.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€57.97
08.07.21
-
08.07.22
5.97%
08.07.22

Sargnagel 
08.07.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€57.97
08.07.21
-
08.07.22
5.97%
08.07.22

Sargnagel 
08.07.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€57.97
08.07.21
-
08.07.22
5.97%
08.07.22

Sargnagel 
08.07.21 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€146.45
08.07.21
-
08.07.22
2.31%
08.07.22

Saftman 
08.07.21 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€98.99
08.07.21
-
08.07.22
50.06%
08.07.22

Saftman 
08.07.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.85
08.07.21
-
08.07.22
-11.18%
08.07.22

Saftman 
08.07.21 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€165.05
08.07.21
-
08.07.22
7.24%
08.07.22

Prof 
08.07.21 50%
buy
Lonza Group AG

Start price
Target price
Perf. (%)
€298.00
08.07.21
-
08.07.22
-
08.07.22

Saftman 
08.07.21 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€142.86
08.07.21
€177.00
08.07.22
22.71%
08.07.22

gerihouse 
08.07.21 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€142.86
08.07.21
€177.00
08.07.22
22.71%
08.07.22

gerihouse 
08.07.21 50%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€86.85
08.07.21
€115.00
08.07.22
13.32%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
08.07.21 80%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€86.85
08.07.21
€115.00
08.07.22
13.32%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
08.07.21 80%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€86.85
08.07.21
€115.00
08.07.22
13.32%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
gerihouse 
08.07.21 80%
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€23.38
30.11.21
€25.00
30.11.22
-71.89%
07.07.22

Could be worthwhile Investment >10% per year
Innovative
Few uniques
me8 
30.11.21 0%
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€154.04
30.10.21
€200.00
31.12.23
11.33%
29.06.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
30.10.21 70%
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€154.04
30.10.21
€200.00
31.12.23
11.33%
29.06.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
30.10.21 70%
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€37.80
13.11.21
€50.00
31.12.23
11.71%
29.06.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
13.11.21 60%
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€79.50
27.06.22
€100.00
27.06.23
40.88%
28.06.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
me8 
27.06.22 0%